Skip to the page

Data / Form D filings / TellBio, Inc.

TellBio, Inc.: Form D filings

TellBio, Inc., a biotechnology company in Andover, MA, filed 7 Form D notices with the SEC between 2019 and 2026. The latest, on March 24, 2026, reports $1 million sold of a $1 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
19 CONNECTOR RD SUITE 4, Andover, MA, 01810
Phone
(781) 249-9550
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1791842

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 24, 2026Amendment$1,000,000$1,000,0006Sep 4, 2024sec.gov
Oct 18, 2024Amendment$1,000,000$1,000,0006Sep 4, 2024sec.gov
Oct 18, 2024New notice$1,000,000$1,000,0006Oct 4, 2023sec.gov
Jul 8, 2024New notice$1,200,000$1,200,00011Jun 21, 2024sec.gov
Mar 29, 2023New notice$2,500,000$2,294,702$205,29823Feb 24, 2023sec.gov
Mar 17, 2021New notice$4,999,998$4,999,99829Mar 11, 2021sec.gov
Oct 22, 2019New notice$1,478,331$1,478,33119Sep 30, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
RICHARD PETERSExecutive Officer, Director
GARY CROCKERDirector
BERNARD PETERSDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Mar 23, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TellBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.